The Orthofix SpinalStim you’re seeing here was given to me by a friend after their doctor said the therapy could be cut short. This provided a somewhat rare opportunity to observe the device ...

A key factor contributing to this optimistic outlook is the planned phase-out of M6-C disc products. Analysts project that this strategic move will serve as a revenue tailwind for Orthofix.

Company to Host Conference Call on Tuesday, May 6, 2025 at 8:30 am Eastern Time Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will ...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA ...

During the quarter, Orthofix announced several product updates. The company is phasing out its M6-C disc products, which contributed approximately $23 million in revenue in 2024 but were seen as a ...

A key factor contributing to this optimistic outlook is the planned phase-out of M6-C disc products. Analysts project that this strategic move will serve as a revenue tailwind for Orthofix.

Company to Host Conference Call on Tuesday, May 6, 2025 at 8:30 am Eastern Time LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc (OFIX). (NASDAQ:OFIX), a leading global medical technology ...